Chapter Two - Diverse Functions of Ceramide in Cancer Cell Death and Proliferation
Section snippets
Structure and Metabolism of Ceramide
Bioactive sphingolipid ceramide can be synthesized through multiple different pathways within the cell. Ceramide is composed of a sphingosine backbone, which is amide-linked to a fatty acyl chain, varying in length from C14 to C26 (Fig. 2.1) (Ogretmen and Hannun, 2004, Ponnusamy et al., 2010). Ceramide serves as a structural precursor for complex sphingolipids, such as sphingomyelin (SM), ceramide-1-phosphate (C1P), or glucosylceramide (GlcCer) and galactosylceramide (GalCer), and precursors
Distinct Functions of CerS1–6
Recent studies indicate that different fatty-acid chain lengths of ceramide may have different functions in cancer pathogenesis, highlighting the importance of ceramide synthases (CerS) in sphingolipid metabolism. CerS, identified as the yeast longevity assurance gene 1 (LAG1), is known to regulate life span/longevity in Saccharomyces cerevisiae, and its deletion prolongs the replicative lifespan of yeast (Guillas et al., 2001, Jazwinski and Conzelmann, 2002). Within Caenorhabditis elegans,
Novel Ceramide–Protein Interactions that Regulate Ceramide Metabolism and Signaling
Diverse and distinct functions of ceramides can be partially explained by the discovery of novel ceramide–protein interactions (Table 2.1). One of the recently identified proteins known to bind to ceramide is CERT. CERT specifically transports ceramide from the ER to the trans-Golgi for SM synthesis (Hanada et al., 2003, Hanada et al., 2009). The crystal structure of CERT suggests that ceramide binds within the hydrophobic core of the protein for transport (Hanada et al., 2003, Hanada et al.,
Clinical Relevance of Ceramide Metabolism and Signaling in Cancer Pathogenesis, Therapy, or Drug Resistance
Recent studies suggest that ceramide has important clinical significance in cancer pathogenesis and prognosis (Fig. 2.3). In 2004, data from our laboratory showed that total ceramide levels were elevated in the majority of HNSCC tissues compared with noncancerous adjacent head and neck tissues (Karahatay et al., 2007). Interestingly, only C18-ceramide, and not other ceramide species, was significantly lower in ∼ 70% of the tumor tissues of HNSCC patients sampled, when compared to controls, and
Ceramide/Sphingosine-Based Anticancer Therapeutics
Pro-cell death function of ceramide suggests that ceramide mimetics or analogues may open doors to new therapies to battle cancer (Table 2.2). Thus, finding ways to increase ceramide either by exogenous treatment or by elevating endogenous ceramide in cancer cells is desired. Conversely, S1P has been shown to promote cancer pathogenesis; thus, suppression of its generation/accumulation could suppress tumor growth as an alternative treatment strategy.
One common approach to promote apoptosis in
Conclusions
Over the past two decades, the field of sphingolipid research has expanded immensely. The importance of sphingolipids, in particular ceramide, is well established in cancer. Previously, ceramide was classified as a “pro-cell death molecule”; however, it is now evident that not all ceramides are created equally, and that ceramides with different fatty-acid chain lengths exhibit distinct biological functions in a context-dependent manner. Although mechanisms that regulate distinct functions of
Acknowledgments
This work was supported by research grants CA088932, DE016572, and CA097132 to B. O. S. A. S was supported by funds from Wachovia Foundation and Abney Foundation, and NIH F30 ES019464.
References (95)
- et al.
Encephalopathy caused by ablation of very long acyl chain ceramide synthesis may be largely due to reduced galactosylceramide levels
The Journal of Biological Chemistry
(2011) - et al.
FTY720 inhibits ceramide synthases and up-regulates dihydrosphingosine 1-phosphate formation in human lung endothelial cells
The Journal of Biological Chemistry
(2009) - et al.
N-acylated serinol is a novel ceramide mimic inducing apoptosis in neuroblastoma cells
The Journal of Biological Chemistry
(2000) - et al.
Phosphorylation of the immunomodulatory drug FTY720 by sphingosine kinases
The Journal of Biological Chemistry
(2003) - et al.
Ceramide directly activates protein kinase C zeta to regulate a stress-activated protein kinase signaling complex
The Journal of Biological Chemistry
(2000) - et al.
Long chain ceramides activate protein phosphatase-1 and protein phosphatase-2A. Activation is stereospecific and regulated by phosphatidic acid
The Journal of Biological Chemistry
(1999) - et al.
FAS activation induces dephosphorylation of SR proteins; dependence on the de novo generation of ceramide and activation of protein phosphatase 1
The Journal of Biological Chemistry
(2001) - et al.
Inhibition of multidrug resistance by adamantylgb3, a globotriaosylceramide analog
The Journal of Biological Chemistry
(2008) - et al.
Role of multiple drug resistance protein 1 in neutral but not acidic glycosphingolipid biosynthesis
The Journal of Biological Chemistry
(2004) - et al.
Increased ceramide synthase 2 and 6 mRNA levels in breast cancer tissues and correlation with sphingosine kinase expression
Biochemical and Biophysical Research Communications
(2010)